Your browser doesn't support javascript.
loading
Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes.
Bancroft, Tara; DeBuysscher, Blair L; Weidle, Connor; Schwartz, Allison; Wall, Abigail; Gray, Matthew D; Feng, Junli; Steach, Holly R; Fitzpatrick, Kristin S; Gewe, Mesfin M; Skog, Patrick D; Doyle-Cooper, Colleen; Ota, Takayuki; Strong, Roland K; Nemazee, David; Pancera, Marie; Stamatatos, Leonidas; McGuire, Andrew T; Taylor, Justin J.
Afiliação
  • Bancroft T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • DeBuysscher BL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Weidle C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Schwartz A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Wall A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Gray MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Feng J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Steach HR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Fitzpatrick KS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Gewe MM; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Skog PD; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA.
  • Doyle-Cooper C; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA.
  • Ota T; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA.
  • Strong RK; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Nemazee D; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA.
  • Pancera M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Stamatatos L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA lstamata@fredhutch.org.
  • McGuire AT; Department of Global Health, University of Washington, Seattle, WA.
  • Taylor JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA amcguire@fredhutch.org.
J Exp Med ; 216(10): 2331-2347, 2019 10 07.
Article em En | MEDLINE | ID: mdl-31345930
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Infecções por HIV / Anticorpos Anti-Idiotípicos / HIV-1 / Células Precursoras de Linfócitos B / Anticorpos Neutralizantes Tipo de estudo: Diagnostic_studies Limite: Adult / Animals / Female / Humans / Male Idioma: En Revista: J Exp Med Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Infecções por HIV / Anticorpos Anti-Idiotípicos / HIV-1 / Células Precursoras de Linfócitos B / Anticorpos Neutralizantes Tipo de estudo: Diagnostic_studies Limite: Adult / Animals / Female / Humans / Male Idioma: En Revista: J Exp Med Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos